Advancing novel antidepressants and anxiolytics based on clinically validated mechanisms powered by our Glyph™ platform.
Uniquely designed to enable oral bioavailability, avoid first-pass metabolism and reduce hepatotoxicity and other side effects.
Papers
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans
